Resultats globals: 24 registres trobats en 0.03 segons.
Articles, 22 registres trobats
Documents de recerca, 2 registres trobats
Articles 22 registres trobats  1 - 10següentfinal  anar al registre:
1.
12 p, 1.4 MB Short- and Long-Term Mortality Trends in STEMI-Cardiogenic Shock over Three Decades (1989-2018): the Ruti-STEMI-Shock Registry / García-García, Cosme (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Oliveras, Teresa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; El Ouaddi, Nabil (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Rueda, Ferran (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Serra Flores, Jordi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Labata, Carlos (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ferrer, Marc (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Cediel, Germán (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Montero, Santiago (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Martínez, Maria Jose (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Resta, Helena (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; de Diego, Oriol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Vila, Joan (Institut Hospital del Mar d'Investigacions Mèdiques) ; Degano, Irene R (Institut Hospital del Mar d'Investigacions Mèdiques) ; Elosua, Roberto (Institut Hospital del Mar d'Investigacions Mèdiques) ; Lupón, Josep (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Bayes-Genis, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Universitat Autònoma de Barcelona. Departament de Medicina
Aims: Cardiogenic shock (CS) is an ominous complication of ST-elevation myocardial infarction (STEMI), despite the recent widespread use of reperfusion and invasive management. The Ruti-STEMI-Shock registry analysed the prevalence of and 30-day and 1-year mortality rates in ST-elevation myocardial infarction (STEMI) complicated by CS (STEMI-CS) over the last three decades. [...]
2020 - 10.3390/jcm9082398
Journal of clinical medicine, Vol. 9 Núm. 8 (2020) , p. 2398  
2.
33 p, 1.7 MB Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials / Ibanez, Borja (Cardiology Department, IIS Fundación Jiménez Díaz Hospital, Madrid, Spain) ; Aletras, Anthony H. (Lund University, Department of Clinical Sciences Lund, Clinical Physiology, Skane University Hospital, Lund, Sweden) ; Arai, Andrew E. (National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland) ; Arheden, Hakan (Lund University, Department of Clinical Sciences Lund, Clinical Physiology, Skane University Hospital, Lund, Sweden) ; Bax, Jeroen (Department of Cardiology, Heart Lung Center, Leiden University Medical Center, Leiden, the Netherlands) ; Berry, Colin (British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, and Golden Jubilee National Hospital, Clydebank, United Kingdom) ; Bucciarelli-Ducci, Chiara (Bristol Heart Institute, Bristol NIHR Cardiovascular Research Centre, University of Bristol and University Hospitals Bristol NHS Trust, Bristol, United Kingdom) ; Croisille, Pierre (University Lyon, UJM-Saint-Etienne, INSA, CNRS UMR 5520, INSERM U1206, CREATIS, F-42023, Saint-Etienne, France) ; Dall'Armellina, Erica (Leeds Institute of Cardiovascular and Metabolic Medicine, Department of Biomedical Imaging Sciences, University of Leeds, Leeds, United Kingdom) ; Dharmakumar, Rohan (Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, and Division of Cardiology, Department of Medicine, University of California, Los Angeles, California) ; Eitel, Ingo (University Heart Center Lübeck, Medical Clinic II (Cardiology/ Angiology/Intensive Care Medicine) and German Center for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck, Lübeck, Germany) ; Fernández-Jiménez, Rodrigo (Cardiology Department, Icahn School of Medicine at Mount Sinai, New York, New York) ; Friedrich, Matthias G. (Department of Medicine, Heidelberg University, Heidelberg, Germany) ; García-Dorado, David (Hospital Universitari Vall d'Hebron. Institut de Recerca ) ; Hausenloy, Derek J. (Tecnologico de Monterrey, Centro de Biotecnologia-FEMSA, Nuevo Leon, Mexico) ; Kim, Raymond J. (Duke Cardiovascular Magnetic Resonance Center, Division of Cardiology, and Department of Radiology, Duke University Medical Center, Durham, North Carolina) ; Kozerke, Sebastian (Institute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland) ; Kramer, Christopher M. (Departments of Medicine and Radiology, University of Virginia Health System, Charlottesville, Virginia) ; Salerno, Michael (Departments of Medicine and Radiology, University of Virginia Health System, Charlottesville, Virginia; and) ; Sánchez-González, Javier (Philips Healthcare, Madrid, Spain) ; Sanz, Javier (Cardiology Department, Icahn School of Medicine at Mount Sinai, New York, New York) ; Fuster, Valentin (Cardiology Department, Icahn School of Medicine at Mount Sinai, New York, New York) ; Universitat Autònoma de Barcelona
After a reperfused myocardial infarction (MI), dynamic tissue changes occur (edema, inflammation, microvascular obstruction, hemorrhage, cardiomyocyte necrosis, and ultimately replacement by fibrosis). [...]
2019 - 10.1016/j.jacc.2019.05.024
Journal of the American College of Cardiology, Vol. 74 (july 2019) , p. 238-256  
3.
14 p, 735.5 KB COVID-19 and Disruptive Modifications to Cardiac Critical Care Delivery / Katz, Jason N. (Division of Cardiology, Duke University, Durham, North Carolina) ; Sinha, Shashank S. (Inova Heart and Vascular Institute, Inova Fairfax Medical Center, Falls Church, Virginia) ; Alviar, Carlos L. (Leon H. Charney Division of Cardiology, New York University Langone Medical Center NYU Langone Medical Center, New York, New York) ; Dudzinski, David M. (Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts) ; Gage, Ann (Division of Cardiology, Cleveland Clinic, Cleveland, Ohio) ; Brusca, Samuel B. (Critical Care Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland) ; Flanagan, M. Casey (Inova Heart and Vascular Institute, Inova Fairfax Medical Center, Falls Church, Virginia) ; Welch, Timothy (Virginia Heart, Falls Church, Virginia) ; Geller, Bram J. (Division of Cardiology, Maine Medical Center, Portland, Maine) ; Miller, P. Elliott (Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut) ; Leonardi, Sergio (Coronary Care Unit and Laboratory of Clinical and Experimental Cardiology-Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy) ; Bohula, Erin A. (TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts) ; Price, Susanna (Royal Brompton and Harefield NHS Foundation Trust, Royal Brompton Hospital, London, United Kingdom) ; Chaudhry, Sunit-Preet (Department of Cardiology, St. Vincent Hospital, Indianapolis, Indiana) ; Metkus, Thomas S. (Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland) ; O'Brien, Connor G. (Division of Cardiovascular Medicine, Stanford University School of Medicine, Palo Alto, California) ; Sionis, Alessandro (Institut d'Investigació Biomèdica Sant Pau) ; Barnett, Christopher F. (Department of Cardiology, Medstar Washington Hospital Center, Washington, DC) ; Jentzer, Jacob C. (Department of Cardiovascular Medicine and Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota) ; Solomon, Michael A. (Cardiovascular Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland) ; Morrow, David A. (TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts) ; van Diepen, Sean (Department of Critical Care and Division of Cardiology, Department of Medicine, University of Alberta Hospital, Alberta, Canada)
The COVID-19 pandemic has presented a major unanticipated stress on the workforce, organizational structure, systems of care, and critical resource supplies. To ensure provider safety, to maximize efficiency, and to optimize patient outcomes, health systems need to be agile. [...]
2020 - 10.1016/j.jacc.2020.04.029
Journal of the American College of Cardiology, Vol. 76 (april 2020) , p. 72-84  
4.
11 p, 2.3 MB First-in-human PeriCord cardiac bioimplant : scalability and GMP manufacturing of an allogeneic engineered tissue graft / Prat-Vidal, Cristina (Institut Germans Trias i Pujol) ; Rodríguez-Gómez, Luciano (Cell Therapy Service, Banc de Sang i Teixits, Edifici Dr. Frederic Duran i Jordà) ; Aylagas, Miriam (Hospital Universitari Vall d'Hebron) ; Nieto-Nicolau, Nuria (Barcelona Tissue Bank (BTB), Banc de Sang i Teixits (BST)) ; Gastelurrutia, Paloma (Institut d'Investigació Biomèdica de Bellvitge - IDIBELL) ; Agustí, Elba (Barcelona Tissue Bank (BTB), Banc de Sang i Teixits (BST)) ; Gálvez-Montón, Carolina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Jorba, Ignasi (Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, CIBERES, University of Barcelona) ; Teis, Albert (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Monguió-Tortajada, Marta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Roura, Santiago (CIBER Cardiovascular, Instituto de Salud Carlos III) ; Vives Armengol, Joaquim ; Torrents-Zapata, Silvia (Cell Therapy Service, Banc de Sang i Teixits) ; Coca, María Isabel (Cell Therapy Service, Banc de Sang i Teixits) ; Reales, Laura (Cell Therapy Service, Banc de Sang i Teixits) ; Cámara-Rosell, María Luisa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Cediel, Germán (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Farré, Ramon (Unit of Biophysics and Bioengineering, School of Medicine and Health Sciences, University of BarcelonaIDIBAPS-CIBERES) ; Navajas, Daniel (Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, CIBERES, University of Barcelona) ; Vilarrodona, Anna (Barcelona Tissue Bank (BTB), Banc de Sang i Teixits (BST)) ; García-López, Joan (Research and Education. Banc de Sang i Teixits, Edifici Dr. Frederic Duran i Jordà, Passeig Taulat, 116, 08005 Barcelona, Spain) ; Muñoz-Guijosa, Christian (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Querol, Sergi (Hospital Universitari Vall d'Hebron) ; Bayes-Genis, Antoni (Universitat Autònoma de Barcelona. Departament de Medicina) ; Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol ; VHIR Vall d'Hebron Institut de Recerca ; Universitat Autònoma de Barcelona. Departament de Medicina
Small cardiac tissue engineering constructs show promise for limiting post-infarct sequelae in animal models. This study sought to scale-up a 2-cm 2 preclinical construct into a human-size advanced therapy medicinal product (ATMP; PeriCord), and to test it in a first-in-human implantation. [...]
2020 - 10.1016/j.ebiom.2020.102729
EBioMedicine, Vol. 54 (april 2020)  
5.
10 p, 653.5 KB Persistence with dual antiplatelet therapy after percutaneous coronary intervention for ST-segment elevation acute coronary syndrome : A population-based cohort study in Catalonia (Spain) / Ribera, A. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ferreira-Gonzalez, I. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Marsal, J.R. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Oristrell, G. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Faixedas, M.T. (Servei Català de la Salut. Generalitat de Catalunya) ; Rosas, A. (Generalitat de Catalunya. Departament de Salut) ; Tizón-Marcos, H. (Institut Hospital del Mar d'Investigacions Mèdiques) ; Rojas, S. (Cardiology Department. Hospital Universitari de Tarragona Joan XXIII. IISPV. Universidad Rovira Virgili) ; Labata, C. (Hospital Universitari Germans Trias i Pujol) ; Cardenas, M. (Hospital Universitari de Girona Doctor Josep Trueta) ; Homs, S. (Cardiology Department. Hospital Mútua de Terrassa) ; Tomas-Querol, C. (Cardiology Department. Hospital Arnau de Vilanova) ; Garcia-Picart, J. (Institut d'Investigació Biomèdica Sant Pau) ; Gomez-Hospital, J.A. (Cardiology Department. Hospital de Bellvitge) ; Pijoan, J.I. (Centro de Investigacion Biomedica en Red en Epidemiologia y Salud Publica CIBERESP. Spanish Health Institute (ISCIII)) ; Masotti, M. (Institut Clínic Cardio Vascular (ICCV). Hospital Clínic de Barcelona) ; Mauri, J. (Hospital Universitari Germans Trias i Pujol) ; Garcia Dorado, D. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Objectives Guidelines recommending 12-month dual antiplatelet therapy (DAPT) in patients with ST-elevation acute coronary syndrome (STEACS) undergoing percutaneous coronary intervention (PCI) were published in year 2012. [...]
2019 - 10.1136/bmjopen-2018-028114
BMJ open, Vol. 9 Núm. 7 (2019) , p. e028114  
6.
29 p, 937.3 KB Sex-specific treatment effects after primary percutaneous intervention : A study on coronary blood flow and delay to hospital presentation / Cenko, E. (Department of Experimental. Diagnostic and Specialty Medicine. University of Bologna) ; van der Schaar, M. (University of Cambridge) ; Yoon, J. (Department of Electrical and Computer Engineering. University of California) ; Kedev, S. (Medical Faculty. University Clinic of Cardiology. University "Ss Cyril and Methodius,") ; Valvukis, M. (Medical Faculty. University Clinic of Cardiology. University "Ss Cyril and Methodius,") ; Vasiljevic, Z. (School of Medicine. University of Belgrade) ; Ašanin, M. (Department of Cardiology. Clinical Centre of Serbia) ; Miličić, D. (Department for Cardiovascular Diseases. University Hospital Center Zagreb. University of Zagreb) ; Manfrini, O. (Department of Experimental. Diagnostic and Specialty Medicine. University of Bologna) ; Badimon, L. (Institut d'Investigació Biomèdica Sant Pau) ; Bugiardini, R. (Department of Experimental. Diagnostic and Specialty Medicine. University of Bologna) ; Universitat Autònoma de Barcelona
Background We hypothesized that female sex is a treatment effect modifier of blood flow and related 30-day mortality after primary percutaneous coronary intervention (PCI) for ST-segment-elevation myocardial infarction and that the magnitude of the effect on outcomes differs depending on delay to hospital presentation. [...]
2019 - 10.1161/JAHA.118.011190
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 8 Núm. 4 (2019) , p. e011190  
7.
6 p, 617.5 KB The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction : rationale and design of the trial / Mathur, Anthony (Queen Mary University of London (UK)) ; Arnold, Roman (Hospital Clínico Universitario de Valladolid) ; Assmus, Birgit (Johann-Wolfgang-Goethe University (Germany)) ; Bartunek, Jozef (VZW Cardiovascular Research Center Aalst (Belgium)) ; Belmans, Ann (KU Leuven-University of Leuven & Universiteit Hasselt (Belgium)) ; Bönig, Halvard (Johann-Wolfgang-Goethe University (Germany)) ; Crea, Filippo (Catholic University of the Sacred Heart (Italy)) ; Dimmeler, Stefanie (Johann-Wolfgang-Goethe University (Germany)) ; Dowlut, Sheik (Queen Mary University of London (UK)) ; Fernández-Avilés, Francisco (Hospital General Universitario Gregorio Marañón) ; Galiñanes, Manuel (Hospital Universitari Vall d'Hebron) ; García Dorado, David (Hospital Universitari Vall d'Hebron) ; Hartikainen, Juha (Kuopio University Hospital and University of Eastern Finland (Finland)) ; Hill, Jonathan (King's College Hospital (UK)) ; Hogardt-Noll, Annette (t2cure (Germany)) ; Homsy, Christian (Celyad SA (Belgium)) ; Janssens, Stefan (University Hospitals Leuven (Belgium)) ; Kala, Petr (Faculty Hospital and Masaryk University (Czech Republic)) ; Kastrup, Jens (Rigshospitalet University of Copenhagen (Denmark)) ; Martin, John (University College London (UK)) ; Menasche, Philippe (University Paris Descartes. Assistance Publique Hopitaux de Paris (France)) ; Miklik, Roman (Faculty Hospital and Masaryk University (Czech Republic)) ; Mozid, Abdul (Barts Heart Centre (UK)) ; San Román, J. Alberto (Hospital Clínico Universitario de Valladolid) ; Sanz-Ruiz, Ricardo (Hospital General Universitario Gregorio Marañón) ; Tendera, Michal (Medical University of Silesia (Poland)) ; Wojakowski, Wojtek (Medical University of Silesia (Poland)) ; Ylä-Herttuala, Seppo (Kuopio University Hospital and University of Eastern Finland (Finland)) ; Zeiher, Andreas (Johann-Wolfgang-Goethe University (Germany)) ; Universitat Autònoma de Barcelona
Over the past 13 years bone marrow-derived mononuclear cells () have been widely investigated for clinical efficacy in patients following acute myocardial infarction (). These early phase trials have used various surrogate markers to judge efficacy and, although promising, the results have been inconsistent. [...]
2017 - 10.1002/ejhf.829
European Journal of Heart Failure, Vol. 19, Issue 11 (November 2017) , p. 1545-1550  
8.
13 p, 6.0 MB Mesenchymal stem cells induce expression of cD73 in human monocytes in vitro and in a swine model of myocardial infarction in vivo / Monguió-Tortajada, Marta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Roura, Santiago (Institut Germans Trias i Pujol) ; Gálvez-Montón, Carolina (Institut Germans Trias i Pujol) ; Franquesa, Marcella (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Bayes-Genis, Antoni (Universitat Autònoma de Barcelona. Departament de Medicina) ; Borràs,Francesc E. (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia)
The ectoenzymes CD39 and CD73 regulate the purinergic signaling through the hydrolysis of adenosine triphosphate (ATP)/ADP to AMP and to adenosine (Ado), respectively. This shifts the pro-inflammatory milieu induced by extracellular ATP to the anti- inflammatory regulation by Ado. [...]
2017 - 10.3389/fimmu.2017.01577
Frontiers in immunology, Vol. 8 (november 2017) , p. 1-13  
9.
9 p, 3.9 MB Noninvasive Assessment of an Engineered Bioactive Graft in Myocardial Infarction: Impact on Cardiac Function and Scar Healing / Gálvez Montón, Carolina (Institut Germans Trias i Pujol. ICREC) ; Bragós, Ramón (Universitat Politècnica de Catalunya. Departament d'Enginyeria Electrònica) ; Soler Botija, Carolina (Institut Germans Trias i Pujol. ICREC) ; Díaz-Güemes, Idoia (Centro de Cirugía de Mínima Invasión Jesús Usón) ; Prat Vidal, Cristina (Institut Germans Trias i Pujol. ICREC) ; Crisóstomo, Verónica (Centro de Cirugía de Mínima Invasión Jesús Usón) ; Sánchez Margallo, Francisco M. (Centro de Cirugía de Mínima Invasión Jesús Usón) ; Llucià Vallperas, Aida (Institut Germans Trias i Pujol. ICREC) ; Bogónez Franco, Francisco Carlos (Universitat Politècnica de Catalunya. Departament d'Enginyeria Electrònica) ; Perea Gil, Isaac (Institut Germans Trias i Pujol. ICREC) ; Roura, Santiago (Institut Germans Trias i Pujol. ICREC) ; Bayes Genis, Antoni (Universitat Autònoma de Barcelona. Departament de Medicina)
Cardiac tissue engineering, which combines cells and biomaterials, is promising for limiting the sequelae of myocardial infarction (MI). We assessed myocardial function and scar evolution after implanting an engineered bioactive impedance graft (EBIG) in a swine MI model. [...]
2017 - 10.5966/sctm.2016-0063
Stem cells translational medicine, Vol. 6 (2017) , p. 647-655  
10.
13 p, 3.7 MB A Cell-Enriched Engineered Myocardial Graft Limits Infarct Size and Improves Cardiac Function / Perea-Gil, Isaac (Institut Germans Trias i Pujol) ; Prat-Vidal, Cristina (Institut Germans Trias i Pujol) ; Gálvez-Montón, Carolina (Institut Germans Trias i Pujol) ; Roura, Santiago (Center of Regenerative Medicine in Barcelona, Barcelona, Spain) ; Llucià-Valldeperas, Aida (Institut Germans Trias i Pujol) ; Soler-Botija, Carolina (Institut Germans Trias i Pujol) ; Iborra Egea, Oriol (Institut Germans Trias i Pujol) ; Díaz-Güemes, Idoia (Jesús Usón Minimally Invasive Surgery Centre, JUMISC, Cáceres, Spain) ; Crisóstomo, Verónica (Jesús Usón Minimally Invasive Surgery Centre, JUMISC, Cáceres, Spain) ; Sánchez-Margallo, Francisco M. (Jesús Usón Minimally Invasive Surgery Centre, JUMISC, Cáceres, Spain) ; Bayes-Genis, Antoni (Universitat Autònoma de Barcelona. Departament de Medicina)
Myocardial infarction (MI) remains a dreadful disease around the world, causing irreversible sequelae that shorten life expectancy and reduce quality of life despite current treatment. Here, the authors engineered a cell-enriched myocardial graft, composed of a decellularized myocardial matrix refilled with adipose tissue-derived progenitor cells (EMG-ATDPC). [...]
2016 - 10.1016/j.jacbts.2016.06.005
JACC: Basic to Translational Science, Vol. 1 (august 2016) , p. 360-372  

Articles : 22 registres trobats   1 - 10següentfinal  anar al registre:
Documents de recerca 2 registres trobats  
1.
1 p, 759.4 KB Induced pluripotent stem cells for post myocardial infarction repair / Rosa Fernández, Eduardo de la ; Bosch i Merino, Assumpció, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
The aim of this review is to study translational aspects of induced pluripotent stem cell technology in cardiac repair after myocardial infarction. This will be achieved by illustrating the current state of the art of this technology and, furthermore, by evaluating the limitations for clinical traslation.
2016
Grau en Ciències Biomèdiques [832]  
2.
1 p, 1.7 MB Zebrafish heart regeneration process : histo-physiological basis & perspectives in regenerative medicine / Gallinat O'Callaghan, Àlex ; Martí Clua, Joaquín, dir. (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2016
Grau en Biologia [812]  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.